RENOWN NEWSROOM

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Becker’s list of Hospitals and Health Systems with Great Psychiatry and Mental Health Programs for 2023 has been published, recognizing professional healthcare leaders across the country.    Renown Health and the University of Nevada, Reno School of Medicine have been recognized among the top programs in the United States. This acknowledgement reflects a commitment from a dedicated team of experienced local professionals providing comprehensive mental health services and advancing the field of psychiatry.    In their announcement, Becker’s highlighted that, “In 2018, a $6 million donation (by the Stacie Mathewson Foundation), funded the creation of the Stacie Mathewson Behavioral Health & Addiction Institute at Renown Health. The institute was formed to address increased prescription drug-related mortality rates and suicide rates in northern Nevada. The department is now fully integrated with University of Nevada School of Medicine's psychiatry residency, child and adolescent psychiatry fellowship programs, and behavioral sciences and clinical psychiatry medical student training. The curriculum emphasizes the value of psychotherapy, psychopharmacology, and interventional psychiatry methods, along with primary care team integration.”   Becker’s editors noted that, “Innovative public and private partnerships with the state include the SOAR early intervention treatment program for those experiencing their first episode of psychosis. A 24-hour crisis stabilization center will open in 2024 for adults with mental health or substance use issues. The Connect Washoe County mental health collaborative, part of the hospital’s community benefit program, hosts the Youth Mental Health Summit, with a number of interventions resulting in reduced use of street and prescription drugs, lower hospitalization rates due to opioid overdose, and fewer cases of intentional suicide mortality in youth.”    “We are honored to be recognized as one of the top psychiatry and mental health programs in the U.S. This achievement reflects the dedication of our integrated team and our unwavering commitment to enhancing the lives of individuals and families affected by mental health challenges. We will continue to strive for excellence and address the diverse needs of individuals struggling with behavioral health issues, said Takesha Cooper, MD, Department Chair of Psychiatry and Behavioral Sciences. “Our team comprises skilled psychiatrists, psychologists, therapists and support staff who collaborate to provide holistic and integrated care for our patients. As the region’s only not-for-profit health system, together with the support of grateful donors like Stacie Mathewson, we will continue to actively engage in outreach initiatives to raise awareness about mental health, reduce stigma and create a community that fosters healing and support.”  Renown Health also earned Forbes' Best Healthcare Employer in Nevada for combatting burnout and ensuring well-being and safety of caregivers. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org. About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

Read More About Reno Home to "Great Psychiatry and Mental Health Program;" Renown and UNR School of Medicine Named to Becker's National List

New mental health benefits and two leaders Top Women in Wellness and HR by Ragan Communications Concern about clinician well-being has been top of mind for years, but the pandemic has exacerbated stress and trauma and presented a unique opportunity to reframe core approaches to fostering a thriving workforce. More than ever, clinicians require compassionate, holistic support to ensure that they feel safe, valued and engaged,” begins the introduction to the 2022 Health Care Talent Scan from the American Hospital Association. In line with this new report, Renown Health President and CEO Tony Slonim, MD, D.Ph., and a newly appointed member of the American Hospital Association Board of Directors, has announced a number of additional benefits to address some of the physical and psychological impacts of chronic clinician workforce stressors and to promote rest-and-recuperation strategies, essential for sustaining high-performing clinical teams. In an enterprise-wide communication, Dr. Slonim wrote to Renown Health employees, “I often say good health is a positive connection of a person’s body, mind and spirit. To honor you this holiday season, we have added to your comprehensive benefits package to help you achieve well-being, realize greater financial security, advance your education, enjoy enhanced life balance, and when needed, face illnesses and setbacks with the greatest possible peace of mind.” In addition to offering a $100 cash holiday gift for all frontline employees (up to manager level), Renown leaders are working to remove the stigma and barriers to using mental health services when needed, and reinforcing that seeking help indicates strength, not weakness. “By listening, recognizing and honoring our team member’s emotional health, we are looking to help each other process these experiences, grow from them and emerge more resilient and available to our patients and families,” said Michelle Sanchez Bickley, MS, SPHR, SHRM-SCP, Chief Human Resources Officer. “This could include taking a day off to refresh and recharge or taking advantage of confidential, mental health counseling visits at no charge. We have updated our policy to include mental and emotional well-being as eligible for use of sick leave.” Sanchez-Bickley is the newest inductee to the HR Hall of Fame this week by Ragan Communications, for leading the charge for health care organizations across the United States in employee health, performance management, Diversity, Equity and Inclusion, training and development, and for implementing innovative employee benefits. She is the only health care HR leader named to the Hall of Fame this year. Also named to the national leadership list is Ann Beck, MBA, Chief Financial Officer, who, Ragan Communications noted, “despite being in the middle of a COVID pandemic and economic and financial down turn, was able to drive performance to secure Renown’s workforce and long-term financing to serve this generation and the next.” In addition, hospital staff will be offered free chair massages, courtesy of a local donor organization, MOBE. “Without a doubt, it’s the little things like this, free chair massages, food trucks at lunch time, a hot cup of coffee near the end of your shift, and a sincere “thank you” from a patient or family, that makes all the difference to us as nurses,” said Jana Elliott, DNP, RN, Associate Chief Nursing Officer Acute Services. Clinicians and employees are also encouraged to take vacation time away, and will continue to earn 10 paid holidays plus vacation time, employee recognition and rewards through the Everyday Amazing employee recognition program, enrollment in a free life insurance plan, and offered paid volunteer time and health insurance, 401k retirement planning, and education and tuition reimbursement. Dr. Slonim ended his communication by saying, “This year, as we readjust, realign and restore our way to a new world, I have never been prouder to ‘Be Renown.’ Thank you for standing by us, offering your time and expertise, and helping us emerge stronger people, and a stronger organization through a very challenging time. Please enjoy this holiday season with family and friends, and know you are appreciated.” Renown Health is currently hiring key roles to support the health and well-being of our community. The HR and Recruiting team are providing applicants with support during the application, interview and onboarding processes with a variety of digital and virtual tools. To join the Renown team to help Fight the Good fight, visit https://careers.renown.org.   About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. In U.S. News and World Report Best Hospital rankings, Renown Regional Medical Center was listed #1 in the State of Nevada. Renown has a long tradition and commitment to improve the care and the health of our community. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Health Leads Nation With Focus on Clinician and Employee Wellness

Treatment offers patients safe, non-drug and non-invasive repetitive transcranial magnetic stimulation (rTMS) therapy to treat symptoms of major depression. Renown Health is committed to improving access to vital mental health services in northern Nevada. Today, clinical leaders at the Stacie Mathewson Behavioral Health & Addiction Institute at Renown announced they will offer repetitive transcranial magnetic stimulation (rTMS) therapy for people experiencing Major Depressive Disorder (MDD) under the guidance of a Renown psychiatrist.  According to the National Institute of Mental Health, major depression is one of the most common mental disorders in the U.S. The disease causes people to experience sadness and helplessness, and in some cases, may prevent people from carrying out their daily routines.  “We at Renown are proud of our national reputation as an innovator in implementing new models, technology and systems of care for our community,” said Tony Slonim, MD, DrPH, President and CEO. “We are working to transform care and demonstrate value in a way that appeals to patients and helps clinicians improve outcomes and reduce costs. There is now a sufficient body of evidence to accept the analgesic and antidepressant effect of high-frequency rTMS, and we are pleased to offer this promising therapy.” rTMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. It is typically used when other depression treatments haven't been effective. This treatment for depression involves delivering repetitive magnetic pulses, so it's called repetitive TMS or rTMS. “Depression can be treated; however, for some people, medications and talking with a behavioral health expert may not be enough,” said Renown’s Division Chief of Behavioral Health, Richard A. Charlat, M.D., M.P.H. “We are pleased to offer rTMS therapy for people looking for a new way to fight depression and for whom other treatments may not have given them relief. We are committed to working closely with our patients to find the treatment that works best for them, so they can live their best lives.” “Nevada has the highest prevalence of mental illness and substance use in the nation,” said Steve Shell, vice president of the Stacie Mathewson Behavioral Health & Addiction Institute. “Combine that with the added stress and isolation many are feeling with the COVID-19 pandemic, and we know that offering patients safe, non-drug and non-invasive treatments- as well as essential mental health and addiction services are more important than ever.”   How rTMS Works During an rTMS session, an electromagnetic coil is placed against the person’s scalp near their forehead. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of the person’s brain involved in mood control and depression. It's thought to activate regions of the brain that have decreased activity in depression. Though the biology of why rTMS works isn't completely understood, the stimulation appears to impact how the brain is working, which in turn seems to ease depression symptoms and improve mood. There are different ways to perform the procedure, and techniques may change as experts learn more about the most effective ways to perform treatments. On average, patients undergo rTMS treatments for four to six weeks, five days a week for about 40 minutes a day. In all cases, a patient’s doctor will determine a treatment plan that’s best for the patient. This video shows what patients can expect during rTMS therapy.    What Does rTMS Feel Like? rTMS therapy is an easy, in-office experience designed to be positive for patients. During treatment, people are awake, alert, and comfortably reclined in a spa-like chair. The first few treatments may cause discomfort at or near the treatment site, however, this is unlikely to last beyond the first week of treatment.1, 2  “The effects of depression can be devastating for the people battling it, as well as for those who love them,” said Stacie Mathewson. “No matter how dark life may seem, always know, there are incredible behavioral health experts at Renown ready to support and empower you as you seek the help you deserve.”  Charles N. and Stacie L. Mathewson established the Stacie Mathewson Behavioral Health & Addiction Institute at Renown in 2018 to expand community access to prevention and intervention services for mental health disorders and alcohol and drug addiction. Renown is working to expand intensive outpatient treatment, partial hospitalization and medication-assisted treatment programs to better serve those struggling with mental illness and addiction. The Renown team is also passionate about prevention, mental wellness and is actively working to decrease stigma and encourage more people to seek the help they need. TMS therapy is cleared by the FDA and available by prescription only. It is commonly covered by most insurance plans. Patients must be referred by a behavioral expert to seek rTMS treatment. For more information and to make a patient referral, please call the Stacie Mathewson Behavioral Health & Addiction Institute at 775-982-5318.   About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.   Sources Trivedi MH, et al. (2006). Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D Implications for Clinical Practice. Am J Psychiatry, 163(1):28-40 Rush AJ, et. al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry, 163(11):1905-1917.

Read More About Renown Now Offering rTMS Treatment for Major Depression

Brings a new level of convenience, access and affordability to surgical care in northern Nevada. In a collaboration designed to offer consumers additional convenient and affordable options for outpatient surgery, Surgery Center of Reno (SCOR) and Renown Health today announced a new partnership. “We are thrilled to bring a new level of convenience in surgical care to patients and providers in the Reno community and outlying areas, to deliver superior clinical quality and service, and make health care more affordable,” said James Lynch, MD, President, and Chairman of the Board of Directors for the Surgery Center of Reno.  “We trust and value the Surgery Center of Reno and its team of surgeons, clinicians and administrators and the excellent quality of care and compassion they provide to their patients,” said Tony Slonim, MD, DrPH, Renown’s President & CEO. “Given our mutual interests in advancing high-quality and high-value care, this partnership expands capabilities, enhances access and affordability for patients and physicians, improves the health of our community and establishes Renown and the Surgery Center of Reno as the premier destination for surgery in northern Nevada.” This joint venture for outpatient surgery care is the result of the unique collaborative relationship between Renown Health, Reno’s only not-for-profit health care system; and the Surgery Center of Reno, an independent physician owned ambulatory surgery center with Regent Surgical Health as the managing partner. The SCOR and Renown partnership brings together three key elements to serve patients and our community with enhanced outpatient surgery care that includes: Out-of-pocket cost savings for patients. Ambulatory Surgical Centers (ASCs) like Surgery Center of Reno, offer a high-quality, low-cost alternative for many surgical procedures. Patient preference and the desire to decrease healthcare costs continue to fuel Renown’s interest in transitioning appropriate surgeries from hospitals to freestanding ambulatory surgery centers. Significant innovations in minimally-invasive surgical procedures along with advances in anesthesia techniques, reduced complications and recovery times for selected procedures, have helped to make ambulatory surgery centers popular. Renown is focused on creating options for high quality, affordable care for patients and insurance providers by having selected surgical procedures occur in the ASC setting. Comfort and convenience for patients. Surgery Center of Reno offers an upscale experience and has some of the most advanced technology for Ambulatory Surgical Centers in the state. Since all surgeries at SCOR are pre-scheduled, a patient’s procedure is never bumped or delayed by an emergency or trauma case. Surgery is scheduled at ideal times for the patient and family. After surgery, the patient has time to wake up in the recovery room, and then recuperate in their own home.  The same high-quality physicians who work in the operating rooms at Renown hospitals also work as part of the Surgery Center of Reno, including surgeons specializing in Spine, Orthopedics, General Surgery, Ear, Nose & Throat, Pain management, Urology/Lithotripsy, Gynecology, Ophthalmology; Dental/ Oral Surgery, Podiatry and Weight Loss Surgery.   Since their inception more than forty years ago, Ambulatory Surgical Centers have demonstrated an ability to deliver quality and customer service while simultaneously reducing costs. The Surgery Center of Reno and all Ambulatory Surgical Centers are highly regulated, adhere to stringent quality and safety guidelines, are certified by Medicare and the Nevada State Department of Health, accredited with accrediting agencies such as the Accreditation Association for Ambulatory Health Care or The Joint Commission, and have adopted extensive patient safety procedures. Of course, if complications or an emergency were to develop, patients have immediate access to Renown’s hospitals.  “Renown has used our experience through COVID-19 to emerge better and stronger, and we are realigning to meet new consumer demands for health and healthcare services that are convenient, accessible and affordable,” said Bethany Sexton, Chief Transformation Officer. “We are excited to partner with SCOR to exceed people’s expectations and to delight our community with smart, innovative approaches to care. As our nation struggles with how to improve a troubled health care system, the experience of ASCs is a great example of a successful transformation in health care delivery.”  Each year, millions of procedures are performed in outpatient centers. The Surgery Center of Reno has been in operation for 14 years, with an excellent track record and reputation in our community. According to a July 2017 report from the Centers for Medicare & Medicaid Services (CMS), about 70 percent of all surgeries in the U.S. occur in an outpatient or ambulatory setting. Outpatient and ambulatory surgery centers can save money and improve the efficiency and convenience of care for patients and health care providers alike. ASCs are at the center of today’s most pressing healthcare initiatives- value based care and risk-sharing models. Nic Towle, RN, Administrator at SCOR says, “We are dedicated to providing excellent care in a safe environment and want all of our patients and their families to be comfortable and receive the highest quality surgical care. Not all procedures can take place in an outpatient setting and may require a hospital stay regardless of your preference. We suggest you speak with your doctor to ensure you qualify as a candidate, to learn about all the options and what is best for you.” About SCOR SCOR is a well-established, Medicare certified, AAAHC accredited, multidisciplinary ambulatory surgery center in Reno. The ASC is partnered with a leader in development and management of ASCs, Regent Surgical Health based in Westchester, Illinois. SCOR has been an integral provider in the market in offering out-patient services to northern Nevada and northeastern California since 2006. SCOR has proven to be a leader in expanding services that include minimally invasive techniques in spine and general surgery. The surgery center has one of the strongest group of fellowship-trained and board-certified specialists and has won multiple awards for clinical excellence. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Surgery Center of Reno To Offer Option for Outpatient Surgery

Under Steve Shell's leadership, the Institute will continue to expand community access to prevention and intervention services for mental health disorders and alcohol and drug addiction. Renown Health is excited to announce Steve Shell is joining the Stacie Mathewson Behavioral Health & Addiction Institute at Renown as its vice president. In this role, Shell will oversee the Institute, which provides intensive outpatient treatment, partial hospitalization programs and medication-assisted treatment to serve those struggling with mental illness and addiction in our community. “We are pleased to welcome such an experienced and talented leader like Steve to our organization,” said Tony Slonim, MD, DrPH, president and CEO, Renown Health. “As vice president of the Stacie Mathewson Behavioral Health & Addiction Institute at Renown, Steve will continue the Institute’s work to change the status of mental health and addiction in northern Nevada.” Shell comes to Renown after opening and serving as chief executive officer of Nevada’s two newest behavioral health hospitals since 2013. He was instrumental in establishing Reno Behavioral Healthcare Hospital in 2016 and helped to design, set up and manage operations for the 124-bed psychiatric and addiction treatment facility for all ages. He also launched the 152- bed Desert Parkway Behavioral Healthcare Hospital in Las Vegas in 2013, a psychiatric and addiction treatment facility for all ages. “Nevada has the highest prevalence of mental illness and substance use in the nation combined with limited access to treatment and a shortage of care providers,” said Steve Shell. “I am passionate about improving the health of our community and have dedicated my career to advocating for mental health, working diligently to further elevate the care offered in our state.”  Renown Health and Charles N. and Stacie L. Mathewson established the Stacie Mathewson Behavioral Health & Addiction Institute at Renown in to expand community access to prevention and intervention services for mental health disorders and alcohol and drug addiction.  The Institute is working to expand intensive outpatient treatment, partial hospitalization programs and medication-assisted treatment to better serve those struggling with mental illness and addiction and is working to decrease stigma and encourage more people to seek help. “Moving the needle and improving the heartbreaking statistics of our state is a key focus for the Institute,” said Stacie Mathewson, executive director at the Stacie Mathewson Foundation. “I believe Steve’s leadership will have a positive impact on our efforts to improve the care and treatment of mental illness and addiction.”      About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

Read More About Steve Shell Joins Renown to Lead the Stacie Mathewson Behavioral Health & Addiction Institute

Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.

Read More About Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Members of the media are invited to meet DANA this morning from 10 a.m. – noon. Please reply to this email or call (775) 691-7308 to coordinate a meet and greet. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” With more than 51,000 study participants enrolled to date, the Healthy Nevada Project® is considered the fastest-enrolling genetic study in the country. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Read More About Introducing Dana Renown Institute for Health Innovations New Life Sized Holographic Kiosk

Today, in accordance with recommendations from the U.S. Surgeon General and the American College of Surgeons, the Renown Health Joint Medical Executive Committee decided that effective Tuesday, March 17, surgical cases scheduled at both Renown Regional Medical Center and Renown South Meadows Medical Center, considered to be ELECTIVE-OPTIONAL will be postponed to a later date.  Patients with scheduled ELECTIVE-OPTIONAL surgeries will be called by Renown Health representatives over the next week. Surgeon’s offices will also be reaching out to assist patients with rescheduling their surgeries for a future date.  Elective surgeries that are REQUIRED and not optional will be evaluated on a case-by-case basis daily with the surgeon, patient and a medical leadership review committee at Renown. Your surgeon’s office will be in contact with you with more information about these REQUIRED surgeries This temporary measure will allow Renown’s physicians and staff to enact the emergency preparedness plans they have been developing for weeks to create additional capacity for inpatients and to continue to deliver high quality care during the anticipated surge in COVID-19 cases in northern Nevada. The new guidelines do NOT apply to EMERGENCY surgeries performed in Renown hospitals. There are different types of surgery, this decision impacts Elective-Optional surgeries only. Elective – Optional surgery – Elective surgeries are not usually necessary for the individual to stay in good health. They are non-emergency and planned in advance. A wide range of surgeries can be elective. Most cosmetic surgeries are elective. Other surgeries such as organ donation, scoliosis surgery, tonsillectomies and other minor surgeries can also be considered elective. Required surgery – Surgery which needs to be done in order to retain quality of life. As opposed to urgent or emergency surgery, required surgeries do not need to be performed immediately. Examples of required surgery are kidney stone or tumor removal. Urgent or emergency surgery – When a patient’s condition is life threatening, surgery is considered emergent. Emergency surgeries must be performed immediately, even when the patient is unconscious and cannot give consent. Examples include trauma and appendicitis. Life-threatening conditions can occur during labor and delivery which may require emergency surgery. Other services making changes include: Pulmonary Services and Procedures Renown Health today will begin rescheduling patients scheduled for Pulmonary Function Testing, Outpatient bronchoscopy and patients at Thomas S. Dolan Pulmonary Rehabilitation. Patients who are affected by this change are being called by Renown to reschedule their appointments for Monday, April20, 2020 or later. Starbucks at Renown and Renown Dining Options As with many of the Starbucks around the U.S., the Starbucks at Renown Regional Medical Center will shift to a “to-go” model, with no seating available. The cafeterias at Renown Regional Medical Center and South Meadows Medical Center remain open, will temporarily eliminate self-service options and will add more ‘grab and go’ options. Other Renown Services Remain Open Renown Medical Group offices remain open. Planned imaging procedures such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRIs), mammograms and non-invasive cardiology testing will continue at Renown hospitals and office locations and will NOT be postponed at this time. Patients confirmed for imaging appointments will be contacted prior to their scheduled visits to identify those who may be at higher risk of COVID-19 infection. Renown has expanded access to Teladoc virtual visits, available to all Hometown Health and Senior Care Plus subscribers. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at https://www.renown.org/covid-19/.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Update on Elective Surgical Procedures and Medical Services

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

Two Open-Heart Surgeons and Two Advanced Practitioners Bring Nearly 70 Years of Local Experience. As part of a continuing focus on offering comprehensive care for patients experiencing cardiac and vascular disease across northern Nevada, Renown Health Department of Surgery and Renown Institute for Heart & Vascular Health have developed Renown’s first division of cardiothoracic surgery dedicated to heart surgery patients. “Today, I am proud to announce cardiothoracic surgeons, Athan Roumanas, M.D., FACS, and Joseph Brandl, M.D., FACS, who have more than 45 years of combined experience caring for northern Nevadans in need of open-heart surgery, will lead this new practice at Renown,” said Anthony Slonim, M.D., Dr.PH., FACHE, President and CEO of Renown Health. “Advanced practitioners Cindy Powers and Ashley White bring another 23 years of expert care to our community and the new division of cardiothoracic surgery.” Dr. Roumanas has 18 years of experience in northern Nevada. He is a clinical associate professor of surgery at the University of Nevada, Reno School of Medicine (UNR Med) and currently serves as medical director of cardiothoracic surgery for Renown Regional Medical Center. Since 1991, Dr. Brandl has cared for our region and held numerous positions throughout the community including Renown’s director of cardiac surgery and community adjunct faculty for UNR Med. Renown Institute for Heart & Vascular Health offers the most highly-skilled and experienced heart and vascular team and the most advanced heart center in the region. Renown has long been the region’s heart care leader – performing the area’s first open-heart surgery, angioplasty, stent and valve replacements decades ago. In 2015, Renown Regional became the first hospital in the region to offer transcatheter aortic valve replacement (TAVR), a lifesaving alternative to open-heart surgery for patients considered high-risk or inoperable. Renown is among the nation’s top-performing hospitals for heart attack treatment and one of only 105 hospitals nationwide to receive the American College of Cardiology ACTION Registry Silver Performance Achievement Award recognizing success in implementing a higher standard of care for heart attack patients. Additionally, Renown’s Roseview, Sierra and Cardiac Intensive Care Units (ICUs) were the only ICUs in Nevada to receive the Beacon Award of Excellence from the American Association of Critical Care Nurses. This distinction is based on sustained unit performance and patient outcomes that exceed national benchmarks. As Reno’s only locally-owned, charitable, not-for-profit integrated health network, Renown continues to meet customer demand for affordable healthcare and enhanced service and access by keeping the highest levels of clinical quality care right here in our community. Patients in need of advanced heart care can speak with their care provider about Renown Medical Group – Specialty Care, which can be reached at 775-982-6270 or visit renown.org/HeartCare.

Read More About Nationally Recognized Heart Surgeons Join Renown Health